About this trial

Metabolic flexibility is a process in which the body can switch energy substrates in different physiological states. This flexibility plays an important role in an individual's health because losing it increases the risk of obesity, metabolic syndrome, insulin resistance, and type 2 diabetes. Considering that humans spend most of their awakening hours in a postprandial (PP) state, an organism's metabolic flexibility (MF) to respond to a standardized meal's consumption would provide information on the individual's metabolic health. The PP response to glucose following an oral glucose tolerance test or consumption of a high-carbohydrate meal is well described; however, few studies assess the FM and PP metabolome using mixed meals with different macronutrients. The investigators address how metabolic flexibility and metabolome change after consuming standardized meals with different macronutrient ratios. Data collection includes clinical and diet information, indirect calorimetry, and capillary blood sampling during fasting and after consumption of standardized meals. Samples are collected weekly for one month. The data will determine the metabolic flexibility and metabolome after consuming standardized meals with different macronutrient ratios.

Eligibility criteria

Qualifiers

be over 18 years of age and under 30 years of age;

without active drug addictions: smoking, alcoholism, and/or drug addiction;

in female subjects: regular menstrual cycles;

give written consent for their inclusion in the study.

Disqualifiers

subjects with any pathology that requires medication or special treatment, such as type 2 diabetes mellitus, high blood pressure, dyslipidemia, polycystic ovary syn-drome, autoimmune, thyroid, kidney, neurological diseases, and cancer;

pregnant or lactating women;

subjects with problems with chewing, salivation, and swallowing.

subjects who only have samples (blood and calorimetry) from one study period (fasting or postprandial);

Trial design

Treatments tested in this trial

  • High carbohydrate challenge
  • High lipid challenge
  • High proteinchallenge

Treatment groups

300 Participants
are divided into 3 treatment groups

Locations

1
Berenice Palacios-Gonzalez14610, Mexico City Mexico

Sponsors and collaborators

Instituto Nacional de Medicina Genomica

Lead sponsor

Universidad Nacional Autonoma de Mexico

Collaborator